Loading...
Phase II Study of Belinostat in Patients With Recurrent or Refractory Advanced Thymic Epithelial Tumors
PURPOSE: Thymic epithelial tumors are rare malignancies, and there is no standard treatment for patients with advanced disease in whom chemotherapy has failed. Antitumor activity of histone deacetylase (HDAC) inhibitors in this disease has been documented, including one patient with thymoma treated...
Na minha lista:
| Main Authors: | , , , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society of Clinical Oncology
2011
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3107761/ https://ncbi.nlm.nih.gov/pubmed/21502553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1200/JCO.2010.32.4467 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|